ClinicalTrials.gov
public full text
Public Domain
RESTORE - Study of AGN1 LOEP to Prevent Secondary Hip Fractures
A randomized controlled trial to evaluate AGN1 to prevent secondary hip fractures in osteoporotic women undergoing treatment of index hip fractures. Up to 2400 subjects will be randomized between a treatment group and a control group. Subjects will be followed for a minimum of 5 years after undergoing hip fracture repair surgery.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- RECONFIRM - Study of AGN1 LOEP in Patients with Osteoporosis#804744
- STRONG - Study of AGN1 LOEP for the Treatment of the Contralateral Femur After Fragility Fracture#1093283
- CONFIRM EXTENSION - Long-term Follow-up Study of Patients Treated with AGN1 LOEP#830947
- S0916, MLN1202 in Treating Patients With Bone Metastases#992038
- Phase III Study to Evaluate the Efficacy and Safety of AGSAVI in Patients With Essential Hypertension#1140526
Record · ID 892774
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive